Qianhai Health Holdings (HKSE:00911) 3-Year Revenue Growth Rate : 8.10% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Qianhai Health Holdings 3-Year Revenue Growth Rate?

Qianhai Health Holdings's Revenue per Share for the six months ended in Dec. 2023 was HK$3.67.

During the past 12 months, Qianhai Health Holdings's average Revenue per Share Growth Rate was -51.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 8.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 54.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was -12.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of Qianhai Health Holdings was 57.10% per year. The lowest was -69.80% per year. And the median was 9.75% per year.

Competitive Comparison of Qianhai Health Holdings's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Qianhai Health Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qianhai Health Holdings's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianhai Health Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Qianhai Health Holdings's 3-Year Revenue Growth Rate falls into.

Qianhai Health Holdings 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Qianhai Health Holdings (HKSE:00911) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Qianhai Health Holdings 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Qianhai Health Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Qianhai Health Holdings (HKSE:00911) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianhai Health Holdings Ltd (HKSE:00911) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

177-183 Wing Lok Street, Room 301-3, 3rd Floor, Wing Tuck Commercial Centre, Sheung Wan, Hong Kong, HKG

Website

https://www.qianhaihealth.com.hk

Qianhai Health Holdings Ltd principally engaged in the sale of health products and electronic component products. It includes Chinese herbal medicines, skin-care and other healthcare products and the sale of information technology components products. The operating segments of the group are Healthcare products and Electronic component products. Healthcare products includes sale of healthcare products including Chinese herbal medicines, skincare and other healthcare products. Electronic component products includes sale of information technology components products including central processing unit and semiconductors. The group's revenue is all derived from Hong Kong.

Executives

Huang Guanchao	2101 Beneficial owner
Shinewing Sas (nominee Services) No. 3 Limited	2501 Other
Hou Chung Man	2501 Other
Tang Chung Wah	2501 Other
Sparkling Rock Limited	2201 Interest of corporation controlled by you
Chong Siew Hoong	2202 Interest of your spouse
Lim Tzea	2101 Beneficial owner
Explorer Rosy Limited
Great Prosperous Limited
Noble Stand Global Limited
Thousands Beauties Limited
Yunnan Energy Investment (h K) Co. Limited	2106 Person having a security interest in shares
Yunnan International Holding Group Limited	2106 Person having a security interest in shares
Yunnan International Supply Chain Limited	2106 Person having a security interest in shares
Yunnan Provincial Energy Investment Group Co., Ltd	2106 Person having a security interest in shares

Qianhai Health Holdings (HKSE:00911) Headlines

No Headlines